Frovatriptan Succinate Tablet shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2025-11-12 · last update 2026-02-24
Manufacturers: Endo Pharmaceuticals, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Frova, Tablet, 2.5 mg (NDC 0603-3718-34) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 11/12/2025 Updated 11/12/2025 Discontinued 11/12/2025 |
| Frova, Tablet, 2.5 mg (NDC 63481-025-09) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 02/24/2026 Updated 02/24/2026 Discontinued 02/24/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)